Southern Advanced Materials, LLC v. Abrams

2023 NY Slip Op 04704
CourtAppellate Division of the Supreme Court of the State of New York
DecidedSeptember 21, 2023
DocketIndex No. 650773/15 Appeal No. 577 Case No. 2022-04949
StatusPublished
Cited by1 cases

This text of 2023 NY Slip Op 04704 (Southern Advanced Materials, LLC v. Abrams) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Southern Advanced Materials, LLC v. Abrams, 2023 NY Slip Op 04704 (N.Y. Ct. App. 2023).

Opinion

Southern Advanced Materials, LLC v Abrams (2023 NY Slip Op 04704)
Southern Advanced Materials, LLC v Abrams
2023 NY Slip Op 04704
Decided on September 21, 2023
Appellate Division, First Department
FRIEDMAN, J.
Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.
This opinion is uncorrected and subject to revision before publication in the Official Reports.


Decided and Entered: September 21, 2023 SUPREME COURT, APPELLATE DIVISION First Judicial Department
Barbara R. Kapnick
David Friedman, Ellen Gesmer, Lizbeth González, John R. Higgitt

Index No. 650773/15 Appeal No. 577 Case No. 2022-04949

[*1]Southern Advanced Materials, LLC, Plaintiff-Respondent-Appellant,

v

Robert S. Abrams etc., et al., Defendants-Appellants-Respondents.


Defendants appeal and plaintiff cross-appeals from an order of the Supreme Court, New York County (Andrea Masley, J.), entered on or about October 7, 2022, which, insofar as appealed and cross-appealed from, denied plaintiff's motion for partial summary judgment and denied in part and granted in part defendants' motion for summary judgment.



DLA Piper LLP (US), New York (Megan Shea Harwick, Joseph G. Finnerty, III, Robert C. Foote III and Emma L. Kramer of counsel), for appellants-respondents.

Seiden Law LLP, New York (Amiad Kushner, Michael Stolper and Olivia Huang of counsel), for respondent-appellant.



FRIEDMAN, J.

The primary question on this appeal is whether an acquisition of a limited liability company, which transaction was structured as a sale of 100 percent of the membership interests in the target company, may be characterized as a dissolution of the company under the terms of its operating agreement. A former preferred shareholder of the target company, seeking to recover the preferred return to which it would be entitled upon a dissolution, argues that the sale of the company's equity should qualify as a dissolution under the operating agreement because the transaction necessarily involved the transfer of control of all of the company's assets and the operating agreement provides that dissolution must occur "upon the disposition by the Company of substantially all of its assets." We are not persuaded by this argument, and therefore modify the order under review to grant defendants summary judgment dismissing the former preferred shareholder's cause of action for breach of contract. We affirm, however, the motion court's grant of summary judgment dismissing the former preferred shareholder's claim for breach of fiduciary duty.

CV Holdings, LLC (CVH), a Delaware limited liability company, was a holding company for a group of operating subsidiaries engaged in the design and manufacture of plastic products.[FN1] Defendant Robert S. Abrams, individually and as trustee of defendant Robert S. Abrams Living Trust (collectively with the trust, Abrams), who held all of CVH's Class A Common Interests, was CVH's manager and majority shareholder.[FN2] Plaintiff Southern Advanced Materials, LLC (SAM) was a holder of Class C Preferred Interests in CVH. At the time relevant to this appeal, SAM's total investment in CVH was $12.3 million, amounting to an 8.43 percent interest in the company.

The rights and obligations of CVH's shareholders among themselves are set forth in the Fourth Amended and Restated Operating Agreement, dated August 1, 2001 (the Operating Agreement). As relevant to this appeal, section 13.3(c) in Article XIII of the Operating Agreement (entitled "Dissolution and Termination") provides, in sum and substance, that, "upon dissolution of the Company,"[FN3] each preferred shareholder of CVH is entitled to a 10 percent preferred return if the amount that would otherwise have been distributed to the preferred shareholder would have provided [*2]an annual return of less than 30 percent upon that shareholder's preferred investment.[FN4]

The rights and obligations of the shareholders in connection with a sale of CVH to a third party are addressed in Article XIV of the Operating Agreement (entitled "Liquidity and Other Transfer Rights"). Section 14.4 sets forth a "Go Along Obligation," under which, in the event Abrams proposes to sell to an unrelated third party all of the Class A Common Interests, upon the satisfaction of certain conditions, the holders of all other classes of interests become obligated to sell to the same third party all of their respective interests "on the same terms and conditions as the Class A Common Members." Thus, in a situation where section 14.4 applies, all shareholders would be compensated based on their respective pro rata interests in the company, without any premium for the preferred shareholders.[FN5]

In 2011, Abrams formed SiO2 Medical Products, Inc. (SiO2) as a startup company to research and develop the production of glass-lined plastic vessels. SiO2 was set up as a separate company wholly owned by Abrams because CVH did not have the financial ability to put on its balance sheet the level of debt that SiO2 required. Pursuant to an Option/Nominee Agreement between Abrams and CVH, Abrams held legal title to SiO2 shares "for the sole and exclusive benefit of CVH" and CVH had an option to acquire SiO2 for $1 at any time that Abrams owned SiO2. In addition, as more fully discussed below, CVH held certain assets and liabilities related to SiO2. At all times relevant to this appeal, SiO2 had no marketable product and no revenues.

In December 2013, Abrams entered into negotiations with Wendel S.A. concerning Wendel's possible purchase of CVH. In the course of the negotiations, Wendel made clear to Abrams that it was not interested in acquiring CVH's assets and liabilities relating to SiO2 and that, as a precondition to the consummation of the purchase, Wendel would require CVH to divest itself of its SiO2-related assets and liabilities.

Ultimately, Abrams, Wendel, CVH, and all CVH common and preferred shareholders (including SAM) entered into a Purchase Agreement, dated December 23, 2014 (the Purchase Agreement). As more fully discussed below — and as has never been disputed — the Purchase Agreement unequivocally provided for a transaction in the form of a purchase by Wendel (through an indirect subsidiary) of all of CVH's equity interests from the shareholders for $360 million. Consistent with the transaction's equity-sale structure, the Purchase Agreement refers to the shareholders of CVH collectively as the "Sellers" and to each shareholder individually as a "Seller," but refers to CVH as the "Target," not as a seller.

Because Wendel, as previously noted, did not wish to acquire CVH's assets and liabilities related to SiO2, the Purchase Agreement provided that, before the closing of Wendel's purchase, CVH would divest itself of those assets and liabilities by transferring [*3]them to Abrams, and would cancel its option to purchase SiO2, through a "Pre-Closing Restructuring" described in a schedule to the agreement.[FN6]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Southern Advanced Materials, LLC v. Abrams
2023 NY Slip Op 04704 (Appellate Division of the Supreme Court of New York, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
2023 NY Slip Op 04704, Counsel Stack Legal Research, https://law.counselstack.com/opinion/southern-advanced-materials-llc-v-abrams-nyappdiv-2023.